miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1

The activation of nuclear factor-kappa B1 (NFκB1) in cancer cells may confer resistance to ionizing radiation (IR). To enhance the therapeutic efficiency of IR in lung cancer, we screened for microRNAs (miRNAs) that suppress NFκB1 and observed their effects on radiosensitivity in a human lung cancer cell line. From time series data of miRNA expression in γ-irradiated H1299 human lung cancer cells, we found that the expression of miR-9 was inversely correlated with that of NFκB1. Overexpression of miR-9 down-regulated the level of NFκB1 in H1299 cells, and the surviving fraction of γ-irradiated cells was decreased. Interestingly, let-7g also suppressed the expression of NFκB1, although there was no canonical target site for let-7g in the NFκB1 3' untranslated region. From these results, we conclude that the expression of miR-9 and let-7g could enhance the efficiency of radiotherapy for lung cancer treatment through the inhibition of NFκB1.

[1]  R. Vobořil,et al.  Sensitization of colorectal cancer cells to irradiation by IL-4 and IL-10 is associated with inhibition of NF-kappaB. , 2007, Neoplasma.

[2]  M. Bittner,et al.  Functional genomics as a window on radiation stress signaling , 2003, Oncogene.

[3]  W. Park,et al.  LIN28B confers radio-resistance through the posttranscriptional control of KRAS , 2009, Experimental & Molecular Medicine.

[4]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[5]  J. Tschopp,et al.  PIDD Mediates NF-κB Activation in Response to DNA Damage , 2005, Cell.

[6]  W. Park,et al.  Identification of radiation-specific responses from gene expression profile , 2002, Oncogene.

[7]  S. Amundson.  Functional genomics in radiation biology: a gateway to cellular systems-level studies , 2008, Radiation and environmental biophysics.

[8]  B. Aggarwal,et al.  Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.

[9]  J. Tschopp,et al.  Signals from within: the DNA-damage-induced NF-kappaB response. , 2006, Cell death and differentiation.

[10]  J. Tschopp,et al.  PIDD mediates NF-kappaB activation in response to DNA damage. , 2005, Cell.

[11]  J. Tschopp,et al.  Signals from within: the DNA-damage-induced NF-κB response , 2006, Cell Death and Differentiation.

[12]  W. Park,et al.  Dcr3 inhibit p53-dependent apoptosis in γ-irradiated lung cancer cells , 2010, International journal of radiation biology.

[13]  N. Perkins,et al.  Good cop, bad cop: the different faces of NF-κB , 2006, Cell Death and Differentiation.

[14]  W. Park,et al.  Flavonoids inhibit the AU-rich element binding of HuC. , 2009, BMB reports.

[15]  N. Perkins,et al.  Good cop, bad cop: the different faces of NF-kappaB. , 2006, Cell death and differentiation.

[16]  M. Chaudhry,et al.  Transcriptional modulation of micro-RNA in human cells differing in radiation sensitivity , 2010, International journal of radiation biology.

[17]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[18]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[19]  B. Aggarwal,et al.  Curcumin Sensitizes Human Colorectal Cancer Xenografts in Nude Mice to γ-Radiation by Targeting Nuclear Factor-κB–Regulated Gene Products , 2008, Clinical Cancer Research.

[20]  Vivian G. Cheung,et al.  Genetic analysis of radiation-induced changes in human gene expression , 2009, Nature.

[21]  A. Mantovani,et al.  Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals , 2009, Proceedings of the National Academy of Sciences.

[22]  R. Preston,et al.  RADIATION BIOLOGY: CONCEPTS FOR RADIATION PROTECTION , 2004, Health physics.

[23]  Imran Babar,et al.  MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. , 2007, Cancer research.

[24]  G. Sethi,et al.  Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. , 2010, Biochimica et biophysica acta.